Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 강상원 | * |
| dc.date.accessioned | 2025-03-17T16:30:08Z | - |
| dc.date.available | 2025-03-17T16:30:08Z | - |
| dc.date.issued | 2025 | * |
| dc.identifier.issn | 0891-5849 | * |
| dc.identifier.other | OAK-36769 | * |
| dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/271371 | - |
| dc.description.abstract | Epidithio-diketopiperazine (ETP) compound is the family of natural fungal metabolites that are known to exert diverse biological effects, such as immunosuppression and anti-cancer activity, in higher animals. However, an enzyme-like catalytic activity or function of the ETP derivatives has not been reported. Here, we report the generation of novel thiol peroxidase mimetics that possess peroxide-reducing activity through strategic derivatization of the core ETP ring structure. The ETP derivatives with small side chains are the bona fide 2-Cys peroxiredoxin (PRX) mimetics that catalyze the H2O2-reducing reaction specifically coupled to the thioredoxin/thioredoxin reductase system. In contrast, the ETP derivatives with linear chains or a heterocyclic group show H2O2-reducing activity in coupling with both thioredoxin and glutathione systems. Moreover, the ETP derivatives with bulky heterocyclic groups almost lose catalytic activity. The 2-Cys PRX mimetics regulate intracellular H2O2 levels, thereby restoring the receptor Tyr kinase signaling and cellular functions disrupted by the absence of 2-Cys PRX in vascular cells. In a rodent model, the 2-Cys PRX mimetics reverse vascular occlusion in the injured carotid arteries by inhibiting smooth muscle hyperplasia and promoting reendothelialization. Thus, this study reveals a novel chemical platform for complementing defective 2-Cys PRX enzymes in biological systems. © 2025 Elsevier Inc. | * |
| dc.language | English | * |
| dc.publisher | Elsevier Inc. | * |
| dc.subject | Dithio-diketopiperazine | * |
| dc.subject | Growth factor receptor | * |
| dc.subject | H<sub>2</sub>O<sub>2</sub> | * |
| dc.subject | Peroxiredoxin | * |
| dc.subject | Vascular disease | * |
| dc.title | The small molecule peroxiredoxin mimetics restore growth factor signalings and reverse vascular remodeling | * |
| dc.type | Article | * |
| dc.relation.volume | 229 | * |
| dc.relation.index | SCIE | * |
| dc.relation.index | SCOPUS | * |
| dc.relation.startpage | 300 | * |
| dc.relation.lastpage | 311 | * |
| dc.relation.journaltitle | Free Radical Biology and Medicine | * |
| dc.identifier.doi | 10.1016/j.freeradbiomed.2025.01.038 | * |
| dc.identifier.wosid | WOS:001423749100001 | * |
| dc.identifier.scopusid | 2-s2.0-85215949434 | * |
| dc.author.google | Kang D.H. | * |
| dc.author.google | Kim J. | * |
| dc.author.google | Lee J. | * |
| dc.author.google | Kang S.W. | * |
| dc.contributor.scopusid | 강상원(55731433900) | * |
| dc.date.modifydate | 20251105115725 | * |